Meditech Pharmaceutical Igtropure (IGF-1LR3)

Igtropure (IGF-1LR3) is a synthetic form of Insulin-Like Growth Factor 1 (IGF-1), modified by a substitution of the arginine at position 3 with leucine (hence the LR3). This modification extends the half-life of the peptide and increases its potency, making it a popular compound in research and sometimes bodybuilding.

Here’s some basic information about Igtropure (IGF-1LR3):

1. What is IGF-1LR3? IGF-1LR3 is a modified version of IGF-1, a naturally occurring protein in the body that promotes cell growth and development. The modification at the third position (from arginine to leucine) enhances its binding affinity to IGF receptors and delays its degradation, allowing for prolonged activity.
2. Uses and Benefits:
   • Growth and Repair: IGF-1LR3 is believed to stimulate muscle growth, increase the number of muscle cells, and aid in faster recovery after physical exertion or injury.
   • Anti-aging Effects: Some studies suggest it can have anti-aging effects by promoting cell regeneration and improving skin elasticity.
   • Fat Loss: By improving metabolism, it might help with fat loss, although its effectiveness for this purpose is still debated.
3. Administration: IGF-1LR3 is typically administered through subcutaneous injection, often in the same way as insulin. It’s generally used in short bursts of therapy.
4. Side Effects:
   • Hypoglycemia: Since it can increase insulin sensitivity, improper use might cause low blood sugar.
   • Joint Pain: Some users report discomfort in their joints.
   • Acromegaly-like symptoms: Overuse may potentially cause abnormal growth of bones and tissues.
5. Legal Status: The legal status of IGF-1LR3 varies by country. In many places, it is classified as a research chemical and is not approved for human consumption.

If you’re referring to a specific brand like Meditech Pharmaceutical and their product Igtropure, that would likely be a branded version of IGF-1LR3 intended for research purposes. Always ensure that any use of peptides or performance-enhancing substances is done in accordance with local laws and under medical supervision, particularly due to the potential risks involved.